OR
Cardiology - Preventive Cardiology
This infographic highlights the major updates from the ACC/AHA 2026 Dyslipidemia Guideline, emphasizing the continued central role of statins in cardiovascular risk reduction. It summarizes new LDL-C and non-HDL-C treatment goals, improved ASCVD risk assessment using the PREVENT™ calculator, earlier use of combination lipid-lowering therapy, and biomarker-guided management with ApoB and Lipoprotein(a). The infographic provides clinicians with a concise overview of contemporary, goal-directed lipid management strategies to optimize long-term ASCVD prevention.
0 Likes
0 Comments
With cardiovascular disease continuing to be a leading global health challenge, Lipid Lens is committed to advancing scientific exchange in lipid management. This forum provides healthcare professionals with a trusted platform to explore evolving treatment strategies and practical clinical approaches to reducing cardiovascular risk and improving patient outcomes.
© 2026 i-rhythm, All Rights Reserved. MSN i-Rhythm does not provide medical advice, diagnosis or treatment.
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.